Folate and folate-PEG-PAMAM dendrimers: Synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice

Bioconjugate Chemistry

Volumn 19, Issue 11, 2008, Pages 2239-2252

  Singh, Prateek ^a   Gupta, Umesh ^a   Asthana, Abhay ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CONTROLLED DRUG DELIVERY; DENDRIMERS; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; MAMMALS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; ORGANIC ACIDS; TARGETED DRUG DELIVERY; TUMORS;

5-FLUOROURACIL; ANTI-CANCER DRUG DELIVERY; DENDRIMER SYNTHESIS; DENDRITICS; EFFECTIVE APPROACHES; FOLATES; FOLIC ACIDS; FOURTH GENERATION; POLYAMIDOAMINE DENDRIMERS; SURFACE TOPOLOGY;

POLYETHYLENE GLYCOLS;

DENDRIMER; FLUOROURACIL; FOLIC ACID; FOLIC ACID POLYAMIDOAMINE CONJUGATE; FOLIC ACID POLYETHYLENEGLYCOL 4000 POLYAMIDOAMINE CONJUGATE; MACROGOL 4000; N HYDROXYSUCCINIMIDE; N HYDROXYSUCCINIMIDE POLYETHYLENEGLYCOL 4000 FOLIC ACID POLYAMIDOAMINE CONJUGATE; POLYAMIDOAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CANCER CELL CULTURE; CELL STRAIN KB; CONTROLLED STUDY; DENDRITE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ELECTROSPRAY MASS SPECTROMETRY; EXPERIMENTAL MOUSE; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; INFRARED SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SQUAMOUS CELL CARCINOMA; STRUCTURE ANALYSIS; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR MODEL;

MUS;

EID: 56749185962     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800125u     Document Type: Article

References (49)

1. Kwon, G. S., and Okano, T. (1996) Polymeric micelles as new drug carriers. Adv. Drug Delivery Rev. 16, 107-16.
2. Brannon-Peppas, L., and Blanchette, J. O. (2004) Nanoparticle and targeted systems for cancer therapy. Adv. Drug Delivery Rev. 56, 1649-59.
3. Brigger, I., Dubernet, C., and Couvreur, P. (2002) Nanoparticles in cancer therapy and diagnosis. Adv. Drug Delivery Rev. 54, 631-51.
4. Duncan, R. (1999) Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. Technol. Today 2, 441-49.
5. Agarwal, A., Asthana, A., Gupta, U., and Jain, N. K. (2008) Tumor and dendrimers: A review on drug delivery aspects. J. Pharm. Pharmacol. 60, 1-19.
6. Bhadra, D., Bhadra, S., Jain, S., and Jain, N. K. (2003) A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 257, 111-24.
7. Tripathi, P. K., Khopade, A. J., Nagaich, S., Shrivastava, S., Jain, S., and Jain, N. K. (2002) Dendrimer grafts for delivery of 5-fluorouracil. Pharmazie 57, 261-64.
8. Kono, K., Liu, M., and Frechet, J. M. J. (1999) Design of dendritic macromolecules containing folate or methotraxate residues. Bioconjugate Chem. 10, 1115-21.
9. Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., and Mule, J., Jr. (2002) Design and function of a dendrimer- based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm. Res. 19 (9), 1310-16.
10. Bhadra, D., Bhadra, S., and Jain, N. K. (2006) PEGylated dendritic nanoparticulate carriers of anticancer drugs. In Nanotechnology for cancer therapy (Amiji, M. M., Ed.) pp 523-549, Chapter 27, Academic Press, New York.
11. Agarwal, A., Saraf, S., Asthana, A., Gupta, U., Tripathi, P. K., Gajbhiye, V., and Jain, N. K. (2008) Ligand based dendritic systems for tumor targeting. Int. J. Pharm. 350, 3-13.
12. Kannan, S., Kolhe, P., Raykova, V., Glibatec, M., Kannan, R. M., Lieh-Lai, M., and Bassett, D. (2004) Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J. Biomater. Sci. Polym. Ed. 15, 311-30.
13. Gurdag, S., Khandare, J., Stapels, S., Matherly, L. H., and Kannan, R. M. (2006) Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjugate Chem. 17, 275-85.
14. Tomalia, D. A., Baker, H., Dewald, J. R., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., and Smith, P. (1985) A new class of polymers: starburst dendritic molecules. Polym. J. 17, 117-32.
15. Tang, M. X., and Redemann, C. T., Jr. (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem. 7, 703-14.
16. Schatzlein, A. G., Zinselmeyer, B. H., Elouzi, A., Dufes, C., Chim, Y. T. A., Roberts, C. J., Davies, M. C., Munro, A., Gray, A. I., and Uchegbu, I. F. (2005) Preferential liver gene expression with polypropylene imine dendrimers. J. Controlled Release 101, 247-58.
17. Bielinska, A., Kukowska-Latallo, J. F., Johnson, J., and Tomalia, D. A., Jr. (1996) Regulation of in vitro gene expression using antisense oligonucleotide or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acid Res. 24, 2176-82.
18. Kukowska-Latallo, J. F., Bielinska, A. U., Johnson, J., Spindler, R., and Tomalia, D. A., Jr. (1996) Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. U.S.A. 93, 4897-02.
19. Kihara, F., Arima, H., Tsutsumi, T., Hirayama, F., and Uekama, K. (2003) In vitro and in vivo gene transfer by optimised a-cyclodextrin conjugate with polyamido amine dendrimer. Bioconjugate Chem. 14, 342-50.
20. Lim, Y. B., Kim, T., Lee, J. W., Kim, S. M., Kim, H. J., Kim, K., and Park, J. S. (2002) Self assembley ternary complex of cationic dendrimer, Cucurbituril and DNA non-covalent strategy in developing a gene delivery. Bioconjugate Chem. 13, 1181-85.
21. Wiener, E. C., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., and Lauterbur, P. C. (1994) Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 31, 1-8.
22. Newkome, G. R., Moorefield, C. N., Baker, G. R., Saunders, M. J., and Grossman, S. H. (1991) Unimolecular micelles. Angew. Chem., Int. Ed. 30, 1178-80.
23. Vandamme, T. F., and Brobeck, L. (2005) Polyamindo amine dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J. Controlled Release 102, 23-38.
24. Chauhan, A. S., Sridevi, S., Chalasani, K. B., Jain, A. K., Jain, S. K., Jain, N. K., and Diwan, P. V. (2003) Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J. Controlled Release 90, 335-43.
25. Agrawal, P., Gupta, U., and Jain, N. K. (2007) Glycoconjugated peptide dendrimers based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 28, 3349-59.
26. Gupta, U., Agashe, H. B., Asthana, A., and Jain, N. K. (2006) Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 7, 649-58.
27. Bhadra, D., Yadav, A. K., Bhadra, S., and Jain, N. K. (2005) Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int. J. Pharm. 295, 221-33.
28. 125I labeled polyamodoamine dendrimers in vivo. J. Controlled Release 65, 133-48.
29. Satija, J., Gupta, U., and Jain, N. K. (2007) Pharmaceutical and biomedical potential of surface engineered dendrimers. Crit. Rev. Ther. Drug Carrier Syst. 24 (3), 261-315.
30. Bhadra, D., Bhadra, S., and Jain, N. K. (2006) PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate. Pharm. Res. 23 (3), 623-33.
31. Gajbhiye, V., Kumar, P. V., Tekade, R. K., and Jain, N. K. (2007) Pharmaceutical and biomedical potential of PEGylated dendrimers. Curr. Pharm. Des. 13, 415-29.
32. Kojima, C., Kono, K., Maruyama, K., and Takagishi, T. (2000) Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem. 11, 910-17.
33. Garin-Chesa, P., Campbell, I., Saigo, P., Lewis, J., Old, L., and Rettig, W. (1993) Trophoblast and ovarian cancer antigen LK26, sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142, 557-67.
34. Lu, Y., and Low, P. S. (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Delivery Rev. 54, 675-93.
35. Choi, Y., Thomas, T., Kotlyar, A., and Islam, M. T., Jr. (2005) Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem. Biol. 12, 35-43.
36. Steenis-van, J. H., Maarseveen-van, E. M., Verbaan, F. J., Verrijik, R., Crommelin, D. J. A., Storm, G., and Hennink, W. E. (2003) Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J. Controlled Release 87, 167-76.
37. Zalipsky, S., Gilon, C., and Zilkha, A. (1983) Attachment of drugs to polyethylene glycols. Eur. Polym. J. 19 (12), 1177-83.
38. Lee, R. J., and Low, P. S. (1994) Delivery of liposomes into cultured KB cells via folate receptor- mediated endocytosis. J. Biol. Chem. 269, 3198-204.
39. Miklis, P., Cagin, T., and Goddard, W. A. (1997) Dynamics of Bengal Rose encapsulated in the Meijer dendrimer box. J. Am. Chem. Soc. 119, 7458-62.
40. Jansen, J. F. G. A., Brabander-van den Berg, E. M. M., and Meijer, E. W. (1994) Encapsulation of guest molecules into a dendritic box. Science 266, 1226-29.
41. Singhai, A. K., Jain, S., and Jain, N. K. (1997) Evaluation of an aqueous injection of Ketoprofen. Pharmazie 52 (2), 149-51.
42. Trasler, J., Deng, L., Melnyk, S., Pogribny, I., Tim, F. H., Sibani, S., Oakes, C., Li, E., James, S. J., and Rozen, R. (2003) Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 24 (1), 39-45.
43. Yoo, H. S., and Park, T. G. (2004) Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Controlled Release 100, 247-256.
44. Wrightson, W. R., Myers, S. R., and Galandiuk, S. (1995) HPLC analysis of 5-Fu and FdUMP in tissue and serum. Biochim. Biophys. Res. Commun. 216, 808-13.
45. Sikka, P. K., and McMartin, K. E. (1998) Determination of the folate transport pathways in culture rat proximal tubule cells. Chem. Biol. Interact. 114, 15-31.
46. Zhao, X. B., and Lee, R. J. (2004) Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv. Drug Delivery Rev. 56, 1193-204.
47. De Wolf, F. A., and Brett, G. M. (2000) Ligand-binding proteins, their potential for application in systems for controlled delivery and uptake of ligands. Pharmacol. Rev. 52 (2), 207-36.
48. Molema, G. (2005) Design of vascular endothelium-specific drug-targeting strategies for the treatment of cancer. Acta Biochim. Pol. 52, 301-10.
49. Roberts, J. C., Bhalgat, M. K., and Zera, R. T. (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) starburst dendrimers. J. Biomed. Mater. Res. 30, 53-65.